Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.

Calcitonin is a sensitive tumor marker for medullary thyroid cancer (MTC) and is useful in preoperative diagnosis and postoperative surveillance for recurrent disease. Calcitonin-negative MTC is a rare occurrence. We present the case of a 68-year-old man with a 6.5 cm sporadic MTC with a 5-cm metastasis in the neck, but only minimally elevated serum calcitonin levels. He underwent total thyroidectomy, resection of internal jugular vein, and limited ipsilateral lymph node dissection. He remains disease-free 12 months after surgery. We review the literature on calcitonin-negative MTC and discuss methods of postoperative surveillance in this subset of patients.

[1]  E. Baudin,et al.  Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  S. Larson,et al.  Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels , 2007, Journal of Nuclear Medicine.

[3]  A. Iagaru,et al.  Detection of Occult Medullary Thyroid Cancer Recurrence with 2-Deoxy-2-[F-18]fluoro-d-glucose-PET and PET/CT , 2007, Molecular Imaging and Biology.

[4]  M. Maranghi,et al.  Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. , 2007, The Journal of clinical endocrinology and metabolism.

[5]  M. Gelos,et al.  Serum calcitonin negative Medullary thyroid carcinoma , 2006, World journal of surgical oncology.

[6]  S. Roman,et al.  Prognosis of medullary thyroid carcinoma , 2006, Cancer.

[7]  P. Dey,et al.  Fine Needle Aspiration Cytology of the Thyroid , 2005, Acta Cytologica.

[8]  Jonathan R. Clark,et al.  Prognostic Variables and Calcitonin in Medullary Thyroid Cancer , 2005, The Laryngoscope.

[9]  P. Iglesias,et al.  Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.

[10]  J. Plukker,et al.  Impact of 18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients with Biochemical Evidence of Recurrent or Residual Medullary Thyroid Cancer , 2004, Annals of Surgical Oncology.

[11]  O. Dirsch,et al.  Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.

[12]  M. Fowler,et al.  Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. , 2000, Thyroid : official journal of the American Thyroid Association.

[13]  H. Holzhausen,et al.  Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation , 2000, Langenbeck's Archives of Surgery.

[14]  J. A. Wells,et al.  Medullary Carcinoma of the Thyroid Gland , 2000, World Journal of Surgery.

[15]  Q. Duh,et al.  Medullary thyroid carcinoma , 2000, Cancer.

[16]  G. Sterrett,et al.  Medullary carcinoma of the thyroid , 1998, Cancer.

[17]  K. Schmid,et al.  ”Atypical” medullary thyroid carcinoma with little or no calcitonin expression , 1998, Virchows Archiv.

[18]  W. Sturtridge,et al.  Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. , 1978, Canadian Medical Association journal.

[19]  F. Singer,et al.  Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. , 1977, The Journal of clinical endocrinology and metabolism.

[20]  S. Lindsay,et al.  Medullary carcinoma of the thyroid gland. , 1965, Archives of pathology.

[21]  O. Gimm.  Surgery for Medullary Thyroid Cancer , 2007 .

[22]  E. Baudin,et al.  Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. , 1995, European journal of endocrinology.

[23]  H. Buhr,et al.  Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. , 1992, Thyroid : official journal of the American Thyroid Association.